Dengue fever [classical dengue]

AB1_DENGUE_FEVER

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A90 Hospital discharge: ICD-9 — 06[1] Hospital discharge: ICD-8 — 06[1] Cause of death: ICD-10 — A90 Cause of death: ICD-9 — 06[1] Cause of death: ICD-8 — 06[1] 2 out of 7 registries used, show all original rules.	66
4. Check minimum number of events None	66
5. Include endpoints None	66
6. Filter based on genotype QC (FinnGen only)	66

Control definitions (FinnGen only)

Control exclude: AB1_ARTHROPOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_DENGUE_FEVER
CONTROL_EXCLUDE	AB1_ARTHROPOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A90
HD_ICD_9	06[1]
HD_ICD_8	06[1]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A90
COD_ICD_9	06[1]
COD_ICD_8	06[1]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dengue fever [classical dengue] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	598	263	328
Only index persons	556	246	310
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	34.94	35.30	34.62
Only index persons	34.77	34.95	34.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	66	36	30
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	42.30	40.95	43.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
62: Matched controls
620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A90

ICD-10 Finland

Dengue fever [classical dengue]

+∞

73.1

R50.9

ICD-10 Finland

Fever, unspecified

8.7

11.4

B34.9

ICD-10 Finland

Viral infection, unspecified

26.8

9.8

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.4

7.1

147

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529406) Shigella sp [Presence] in Stool by Culture

9.95

8.72

1.0

1.2

—

(3025941) Bacteria identified in Stool by Culture

7.13

8.24

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

8.89

7.33

1.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

8.89

7.33

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

11.16

4.66

1.8

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

11.16

4.66

1.8

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3.93

4.51

2.4

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4.25

4.46

1.1

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3.67

4.11

1.5

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3.67

4.11

1.5

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

13.00

3.84

1.2

1.0

—

(40758558) Short blood count panel - Blood

121

2.72

3.52

6.9

7.5

—

(42870588) Differential panel, method unspecified - Blood

168

2.59

3.48

6.5

6.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

9.27

3.33

1.2

1.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3.03

3.25

1.5

2.1

—

(3021589) Normoblasts [#/volume] in Blood

234

2.47

3.18

7.6

9.0

0.0

e9/l

0.00

190

(3023368) Bacteria identified in Blood by Culture

101

2.58

2.94

3.4

4.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

5.45

2.81

1.7

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.64

2.78

1.3

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

6.47

2.76

1.2

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

302

2.37

2.73

8.6

10.7

3.1

3.9

e9/l

1.92

272

(3029634) Reagin Ab [Titer] in Serum by VDRL

5.08

2.67

3.6

1.9

—

(3019198) Lymphocytes [#/volume] in Blood

269

2.24

2.54

6.6

5.8

1.8

e9/l

0.15

243

(3001604) Monocytes [#/volume] in Blood

262

2.19

2.45

6.7

5.8

0.5

0.6

e9/l

1.39

236

(3006315) Basophils [#/volume] in Blood

262

2.19

2.45

6.7

5.9

0.0

e9/l

0.09

238

(3018095) Leukocytes [#/volume] in Urine

178

2.12

2.25

3.1

5.8

15.3

e6/l

1.32

119

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

4.60

2.20

4.0

1.9

—

(3012544) pH of Venous blood

3.23

2.01

4.0

4.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3.43

1.94

3.0

1.2

39.0

39.2

nmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.99

1.86

1.8

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2.44

1.80

1.7

1.8

28.8

29.0

u/l

0.01

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.13

1.61

2.7

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

140

1.86

1.45

2.4

2.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.32

1.40

2.0

3.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.26

1.37

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

532

2.40

1.35

14.4

12.0

41.0

40.8

0.17

440

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

170

1.76

1.31

2.4

2.5

—

(40768443) Skin Pathology biopsy report

2.92

1.31

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.92

1.31

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.18

1.24

1.7

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.76

1.24

1.2

1.1

—

(36304419) Bacteria [Presence] in Urine

131

1.76

1.18

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2.14

1.16

1.3

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.49

1.11

1.2

1.9

—

(3015736) pH of Urine

200

1.59

0.99

2.8

2.7

—

(3002385) Erythrocyte distribution width [Ratio]

474

1.77

0.96

15.1

14.7

13.1

13.5

2.26

468

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.71

0.91

1.4

1.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.10

0.89

1.3

2.4

0.0

0.1

e6/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.03

0.87

1.5

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.80

0.85

1.6

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

126

1.59

0.81

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.81

0.80

8.4

8.0

1.0

1.1

mmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

355

1.50

0.79

3.8

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.71

0.78

2.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.64

0.73

1.4

2.5

25.7

25.6

—

(3000991) Gas panel - Venous blood

1.92

0.70

7.6

4.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.85

0.67

1.0

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.59

0.67

2.3

2.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.78

0.65

1.0

1.2

—

(1761868) Lipid panel - Serum or Plasma

224

0.68

0.64

3.1

2.5

—

(3022313) Gas panel - Capillary blood

0.00

0.61

0.0

2.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.61

0.0

1.7

—

70.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.61

0.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.61

0.0

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.78

0.59

2.0

1.9

3.0

1.1

g/l

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.58

0.57

1.7

2.5

g/l

—

(40768804) Tissue Pathology biopsy report

192

1.39

0.56

2.1

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

110

1.47

0.55

2.9

3.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.47

0.54

1.7

2.6

15.5

16.2

umol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

107

0.61

0.54

2.3

2.1

—

(3032080) INR in Blood by Coagulation assay

165

1.40

0.54

5.9

6.8

1.2

1.1

inr

—

(3044640) Blood type and Crossmatch panel - Blood

140

0.66

0.50

2.0

2.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

122

1.41

0.48

1.5

1.6

2.5

g/l

1.95

(3007853) Bacteria identified in Skin by Aerobe culture

1.48

0.48

1.0

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.48

0.48

1.7

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

234

0.74

0.46

3.2

4.1

—

(3022145) Colonoscopy Study observation

1.46

0.44

1.5

1.4

—

(3044889) 12 lead EKG panel

346

1.31

0.44

2.6

3.3

—

(3000492) Spirometry study

1.40

0.43

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1.44

0.41

1.6

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

117

1.37

0.40

1.7

1.8

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.42

0.39

1.4

1.3

442.8

876.0

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.41

0.37

1.5

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

397

1.24

0.29

3.1

3.3

—

(3026008) Bacteria identified in Urine by Culture

124

1.27

0.27

2.0

2.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

0.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

3.6

—

57.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

3.3

—

3.9

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

49.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.9

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.21

0.0

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

3.5

—

(3012501) Base excess in Blood by calculation

0.00

0.21

0.0

2.6

—

2.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.21

0.0

2.6

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

2.6

—

8.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

2.6

—

194.8

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

2.6

—

5.1

—

(3002256) Pathology report gross observation

1.21

0.19

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

111

1.21

0.17

1.2

1.3

79.3

24.4

iu/ml

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

171

1.16

0.14

2.1

1.9

106.8

98.1

pmol/l

0.63

(3001122) Ferritin [Mass/volume] in Serum or Plasma

220

1.14

0.14

2.5

2.8

213.3

106.5

ug/l

0.54

200

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

199

0.87

0.14

2.6

2.5

82.1

73.4

nmol/l

0.75

180

(3027945) Reticulocytes/100 erythrocytes in Blood

1.18

0.10

1.0

3.8

1.1

2.0

—

(3000494) Fungus identified in Specimen by Culture

1.06

0.09

1.3

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

109

1.12

0.06

1.4

1.8

0.4

1.1

mg/l

—

(21494755) Public health laboratory ask at order entry panel

1.13

0.06

1.1

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

130

0.91

0.05

4.2

4.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

112

1.09

0.03

1.2

1.3

6.0

3.2

u/ml

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

203

1.05

0.01

2.5

3.0

—

(3003694) ABO and Rh group [Type] in Blood

166

0.95

0.00

1.7

1.6

—

(3013512) EKG study

133

0.97

0.00

3.5

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1.06

0.00

1.7

1.6

23.6

20.7

nmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

162

0.98

0.00

2.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

172

0.98

0.00

4.0

3.4

25.8

18.0

ng/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.8

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

3.0

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(4211845)

0.00

0.0

1.4

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.0

2.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

8.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

0.92

0.00

3.1

2.0

2.2

3.3

mg/l

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

0.0

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

0.90

0.00

5.6

2.3

224.6

78.0

ug/g

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.0

4.2

—

52.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

2.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.0

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

18.7

—

1555.7

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

13.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

11.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.0

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3010503) CD19 cells [#/volume] in Blood

0.00

0.0

1.7

—

0.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

15.5

—

829.0

—

(40768797) Stomach Pathology biopsy report

0.90

0.00

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

6.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.3

—

(40761511) CBC panel - Blood by Automated count

582

1.13

0.00

10.0

11.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(36660697) Celiac disease serology panel - Serum

0.96

0.00

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.1

—

(4268621)

0.00

0.0

2.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

0.0

1.3

—

92.7

—

(1616796) Gas panel - Central venous blood

0.00

0.0

4.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.00

0.00

5.0

5.3

176.2

249.5

u/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

3.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_DENGUE_FEVER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_DENGUE_FEVER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_DENGUE_FEVER – Dengue fever [classical dengue]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dengue fever [classical dengue]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints